Draft Technology Assessment Now Available for Review
The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment Program has posted a draft technology assessment for review entitled "Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee."
If you are interested in reviewing this document, please visit: http://www.ahrq.gov/research/
If you have any questions, please contact ahrqtap@ahrq.hhs.gov.
Technology Assessment for Public Comment
Call for Public Review
Preliminary Technology Assessment for Public Comment
The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment (TA) Program develops systematic reviews, health technology assessments, and other reports at the request of the Centers for Medicare & Medicaid Services (CMS) Coverage and Analysis Group. These reports are funded by an Interagency Agreement from CMS to AHRQ and used to inform national coverage policies, discussion at public Medicare Evidence Development and Coverage Advisory Committee (MedCAC) meetings, and/or for other policy considerations.
To get complete public review, the AHRQ TA Program will post draft reports on the AHRQ TA Web site. To meet the timelines for Medicare coverage decisions mandated by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, draft technology assessment reports will be available for public review for a limited time. A notice will be sent out on the AHRQ Effective Health Care Email distribution list 1 week before the posting of draft reports. Each report will be available for public review on this Web site for a total of 2 weeks.
AHRQ's TA Program supports and is committed to the transparency of its review process. Therefore, starting March 18, 2009, invited peer review comments and public review comments will be publicly posted on the TA Program Web site at http://www.ahrq.gov/research/findings/ta/index.html within 3 months after the associated final report is posted on this Web site. The report authors' responses to the comments (the "disposition of comments") will be posted on the same Web page as the associated comments.
Note: Comments received after the review period will not be accepted.
Date Available: December 15, 2014, 9:00 am ET to January 12, 2015, 5:00 pm ET (extended due to the holidays)
Submit Comments: To submit your comments on this draft for review, go to http://www.ahrq.gov/apps/tapr_form4/
Pain Management Injection Therapies for Low Back Pain (PDF File, 1.74 MB; Appendix PDF File, 2.25 MB)
Date Available: December 1, 2014, 9:00 am ET to December 15, 2014, 5:00 pm ET
Submit Comments: To submit your comments on this draft for review, go to http://www.ahrq.gov/apps/tapr_form2/
Use of Cardiac Resynchronization Therapy in the Medicare Population (PDF File, 1.95 MB; Appendix PDF File, 3.64 MB)
Date Available: December 1, 2014, 9:00 am ET to December 15, 2014, 5:00 pm ET
Submit Comments: To submit your comments on this draft for review, go to http://www.ahrq.gov/apps/tapr_form3/
Persons with disabilities experiencing problems accessing portions of the PDF files for draft reports should contact the Technology Assessment Program at ahrqtap@ahrq.hhs.gov.
If you have any problems with your submission, please Email your comments along with a statement indicating your acceptance of the AHRQ Technology Assessment Program Public Review disclosure policy to tareview@ahrq.hhs.gov. Thank you.
To get complete public review, the AHRQ TA Program will post draft reports on the AHRQ TA Web site. To meet the timelines for Medicare coverage decisions mandated by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, draft technology assessment reports will be available for public review for a limited time. A notice will be sent out on the AHRQ Effective Health Care Email distribution list 1 week before the posting of draft reports. Each report will be available for public review on this Web site for a total of 2 weeks.
AHRQ's TA Program supports and is committed to the transparency of its review process. Therefore, starting March 18, 2009, invited peer review comments and public review comments will be publicly posted on the TA Program Web site at http://www.ahrq.gov/research/findings/ta/index.html within 3 months after the associated final report is posted on this Web site. The report authors' responses to the comments (the "disposition of comments") will be posted on the same Web page as the associated comments.
Review Steps
When a draft Technology Assessment report is available for review, you may review the draft report by completing the associated review form and then selecting "Submit" on the form.Note: Comments received after the review period will not be accepted.
Currently Available for Review
Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee Pain (PDF File, 2.4 MB)Date Available: December 15, 2014, 9:00 am ET to January 12, 2015, 5:00 pm ET (extended due to the holidays)
Submit Comments: To submit your comments on this draft for review, go to http://www.ahrq.gov/apps/tapr_form4/
Pain Management Injection Therapies for Low Back Pain (PDF File, 1.74 MB; Appendix PDF File, 2.25 MB)
Date Available: December 1, 2014, 9:00 am ET to December 15, 2014, 5:00 pm ET
Submit Comments: To submit your comments on this draft for review, go to http://www.ahrq.gov/apps/tapr_form2/
Use of Cardiac Resynchronization Therapy in the Medicare Population (PDF File, 1.95 MB; Appendix PDF File, 3.64 MB)
Date Available: December 1, 2014, 9:00 am ET to December 15, 2014, 5:00 pm ET
Submit Comments: To submit your comments on this draft for review, go to http://www.ahrq.gov/apps/tapr_form3/
Persons with disabilities experiencing problems accessing portions of the PDF files for draft reports should contact the Technology Assessment Program at ahrqtap@ahrq.hhs.gov.
If you have any problems with your submission, please Email your comments along with a statement indicating your acceptance of the AHRQ Technology Assessment Program Public Review disclosure policy to tareview@ahrq.hhs.gov. Thank you.
Questions
Please contact ahrqtap@ahrq.hhs.gov if you have any questions.Page last reviewed December 2014
Internet Citation: Technology Assessment for Public Comment: Call for Public Review. December 2014. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/ta/call-for-public-review.html
.png)
No hay comentarios:
Publicar un comentario